期刊文献+

SUMO-2/3与孕激素受体的共价结合及其对该受体转录活性的调节 被引量:2

SUMO-2/3 can covalently bind to progesterone receptor B to regulate its transcriptional activity
下载PDF
导出
摘要 目的研究B型孕激素受体(progesterone receptor B type;PRB)是否能被SUMO-2、SUMO-3类泛素化修饰,并探讨这种修饰对孕激素受体转录活性的影响。方法以人的MCF-7 cDNA为模板进行PCR反应,扩增出SUMO-2、SUMO-3的cDNA,构建真核表达载体pcDNA3FLAG-SUMO2与pcDNA3FLAG-SUMO3;将质粒pXJ40-myc-PRB分别与pcDNA3-FLAG、pcDNA3FLAG-SUMO2、pcDNA3FLAG-SUMO3共转染人胚肾细胞293T,运用免疫共沉淀及western印迹的方法检测其是否发生类泛素化修饰;运用测定荧光素酶报告基因的方法检测类泛素化修饰对孕激素受体转录活性的影响。结果构建成功表达载体pcDNA3FLAG-SUMO2与pcDNA3FLAG-SUMO3;免疫共沉淀实验证实sumo2/3均可以与PRB共价结合;SUMO-2、SUMO-3能以孕激素依赖的方式增强PRB的转录活性。结论 SUMO-2、SUMO-3分子能够对孕激素受体PRB进行类泛素化修饰,并调节其分子功能。 Objective To investigate whether progesterone receptor B(PRB) can be sumoylated by SUMO-2/3 and the effect of sumoylation on PRB transcriptional activity.Methods SUMO-2/3 cDNA was amplified from MCF-7 cDNA and cloned into the eukaryotic expression vector pcDNA3-FLAG.The plasmid pXJ40-myc-PRB was cotransfected with pcDNA3FLAG-SUMO2,pcDNA3FLAG-SUMO3 or the mock control into 293T cells,and PRB sumoylation was detected by immunoprecipitation and Western blotting.The effect of PRB sumoylation on its transcriptional activity was determined using reporter luciferase assay.Results pcDNA3FLAG-SUMO2 and pcDNA3FLAG-SUMO3 vectors were successfully constructed.SUMO-2/3 could bind covalently to PRB and increase its transcriptional dependent on the presence of progesterone.Conclusion PRB can be sumoylated by SUMO-2/3 and its function is regulated by this modification.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第9期1493-1497,共5页 Journal of Southern Medical University
基金 国家自然科学基金(30670439) 北京市自然科学基金(7112101)~~
关键词 SUMO-2 SUMO-3 PRB 转录活性 类泛素化修饰 SUMO-2 SUMO-3 progesterone receptor B transcription activity sumoylation
  • 相关文献

参考文献18

  • 1Li X, O'malley BW. Unfolding the action of progesterone receptors [J]. J Biol Chem, 2003, 278(41): 39261-4.
  • 2Groshong SD, Owen GI, Grimison B, et al. Biphasic regulation of breast Cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1) [J]. Mol Endocrinol, 1997, 11 (11): 1593-607.
  • 3Elledge RM, Mcguire WL, Osborne CK. Prognostic factors in breast Cancer[J]. Semin Oncol, 1992, 19: 244-53.
  • 4Horwitz KB, Mcguire WL. Specific progesterone receptors in human breast Cancer[J]. Steroids, 1975, 25(4): 497-505.
  • 5Harmoun Z, Greenhough S, Jaffray E, et al. Post-translational modification by SUMO[J]. Toxicology, 2010, 278(3): 288-93.
  • 6Abdel-Hafiz H, Dudevoir ML, Horwitz KB. Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation [J]. J Biol Chem, 2009, 284(14): 9099-108.
  • 7Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition [J]. Nat Rev Mol Cell Biol, 2010, 11(12): 861-71.
  • 8Kang J. Christian B gocke and hongtao Yu.phosphorylation- facilitated sumoylation of MEF2C negatively regulates its transcriptional activity[J]. BMC Biochem, 2006: 5.
  • 9Yang Y, Fu W, Chen J, et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress [J]. Nat Cell Biol, 2007, 9(11): 1253-62.
  • 10Castillo-Lluva S, Tatham MH, Jones RC, et al. SUMOylation of the GTPase Racl is required for optimal cell migration [J], Nat Cell Biol, 2010, 12(11): 1078-85.

同被引文献45

  • 1Pourcet B, Pineda- Torra I, Derudas B, et al. SUMOylation of human peroxisome proliferator-activated receptor alpha in?hibits its trans-activity through the recruitment of the nuclear corepressor NCoR. J BioI Chern, 2010,285 : 5983 -5992.
  • 2Venteclef N, Jakobsson T, Ehrlund A, et al. GPS2-depend?ent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase re?sponse. Genes Dev, 2010, 24 : 381 -395.
  • 3Heng JC, Feng B, Han J, et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell, 2010, 6 : 167 - 174.
  • 4Picard N, Caron V, Bilodeau S, et al. Identification of es?trogen receptor 13 as a SUMO-l target reveals a novel phos?phorylated sumoylation motif and regulation by glycogen syn?thase kinase 313. Mol Cell Biol,2012,32 : 2709 -2721.
  • 5Coffey K, Robson CN. Regulation of the androgen receptor by post-translational modifications. J Endocrinol, 2012, 215 : 221 -237.
  • 6Holmstrom SR, Chupreta S, So A Y, et al. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity de?pends on stable assembly at the promoter but not on DAXX. Mol Endocrinol, 2008, 22: 2061 -2075.
  • 7Chung SS, Ahn BY, Kim M, et al. SUMO modification se?lectively regulates transcriptional activity of peroxisome-pro?liferator-activated receptor "I in C2C12 myotubes. Biochem J, 2011 , 433 : 155 - 161.
  • 8Dawson MI, Xia Z. The retinoid X receptors and their lig?ands. Biochim Biophys Acta, 2012, 1821 : 21 -56.
  • 9Hwang EJ, Lee JM, Jeong J, et al. SUMOylation of RORalpha potentiates transcriptional activation function. Biochem Biophys Res Commun, 2009, 378 : 513 - 517.
  • 10Hu G, Xu C, Staudinger JL. Pregnane X receptor is SU?MOylated to repress the inflammatory response. J Pharma?col Exp Ther, 2010, 335 : 342 - 350.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部